ESPOSITO, Elisabetta
 Distribuzione geografica
Continente #
NA - Nord America 18.165
AS - Asia 10.294
EU - Europa 7.112
SA - Sud America 1.644
AF - Africa 224
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 4
Totale 37.455
Nazione #
US - Stati Uniti d'America 17.784
SG - Singapore 3.980
CN - Cina 2.425
FI - Finlandia 2.242
BR - Brasile 1.299
IT - Italia 1.230
VN - Vietnam 1.058
UA - Ucraina 884
HK - Hong Kong 822
DE - Germania 797
GB - Regno Unito 566
TR - Turchia 491
FR - Francia 320
JP - Giappone 301
IN - India 293
BD - Bangladesh 248
SE - Svezia 246
RU - Federazione Russa 232
PL - Polonia 168
MX - Messico 160
CA - Canada 159
ID - Indonesia 133
AR - Argentina 117
IQ - Iraq 108
ZA - Sudafrica 86
NL - Olanda 77
AT - Austria 65
EC - Ecuador 58
CO - Colombia 57
PK - Pakistan 56
ES - Italia 47
LT - Lituania 43
BE - Belgio 42
TH - Thailandia 36
SA - Arabia Saudita 33
KR - Corea 31
PH - Filippine 31
VE - Venezuela 31
CL - Cile 27
MY - Malesia 27
MA - Marocco 25
RO - Romania 25
UZ - Uzbekistan 25
JO - Giordania 23
IR - Iran 22
IL - Israele 20
AE - Emirati Arabi Uniti 19
NP - Nepal 19
DZ - Algeria 17
EG - Egitto 17
TN - Tunisia 17
PE - Perù 16
PY - Paraguay 16
ET - Etiopia 15
CH - Svizzera 14
EE - Estonia 13
KE - Kenya 13
KZ - Kazakistan 12
PT - Portogallo 12
TW - Taiwan 12
UY - Uruguay 12
CZ - Repubblica Ceca 11
LV - Lettonia 11
AL - Albania 10
BO - Bolivia 10
CR - Costa Rica 10
NG - Nigeria 10
AU - Australia 9
AZ - Azerbaigian 9
DK - Danimarca 9
DO - Repubblica Dominicana 9
OM - Oman 9
HN - Honduras 8
IE - Irlanda 8
KW - Kuwait 8
BF - Burkina Faso 7
JM - Giamaica 7
BG - Bulgaria 6
GR - Grecia 6
GT - Guatemala 6
KG - Kirghizistan 6
MD - Moldavia 5
PA - Panama 5
SN - Senegal 5
AM - Armenia 4
CI - Costa d'Avorio 4
GE - Georgia 4
HR - Croazia 4
HU - Ungheria 4
NI - Nicaragua 4
AO - Angola 3
BH - Bahrain 3
BY - Bielorussia 3
LB - Libano 3
LK - Sri Lanka 3
MN - Mongolia 3
NO - Norvegia 3
QA - Qatar 3
SK - Slovacchia (Repubblica Slovacca) 3
TJ - Tagikistan 3
Totale 37.412
Città #
Singapore 2.424
Ashburn 2.154
Helsinki 2.012
Woodbridge 1.498
Fairfield 1.482
Houston 1.144
San Jose 1.106
Jacksonville 957
Santa Clara 886
Chandler 835
Hong Kong 791
Beijing 783
Ann Arbor 670
Seattle 607
Wilmington 539
Cambridge 494
Ho Chi Minh City 362
Ferrara 349
Dallas 320
Izmir 311
New York 288
Los Angeles 281
Tokyo 279
Nanjing 257
Munich 248
Hanoi 245
Princeton 228
Lauterbourg 200
Boardman 171
Council Bluffs 155
Warsaw 151
São Paulo 138
San Diego 127
Shanghai 103
Mexico City 101
Milan 96
Shenyang 84
London 83
Jakarta 81
Nanchang 81
Buffalo 77
Chicago 74
Hefei 70
Montreal 70
Orem 70
Brooklyn 63
Dearborn 63
Frankfurt am Main 58
Chennai 57
Hebei 55
Jiaxing 55
Changsha 54
Bologna 52
Johannesburg 50
Redwood City 49
Vienna 49
Da Nang 47
Moscow 46
Tianjin 45
Haiphong 44
Rio de Janeiro 44
Stockholm 43
Atlanta 42
Baghdad 41
Denver 41
Brussels 39
Turku 39
Poplar 38
Boston 37
Mumbai 37
San Francisco 37
The Dalles 35
Jinan 33
Rome 33
Toronto 33
Belo Horizonte 32
Manchester 32
Norwalk 32
Ankara 31
Falkenstein 30
San Mateo 30
Mountain View 28
Falls Church 26
Guangzhou 26
Ningbo 26
Washington 24
Addison 23
Curitiba 23
Tashkent 22
Amsterdam 21
Bengaluru 21
Kunming 21
Amman 20
Biên Hòa 20
Charlotte 20
Guayaquil 20
Indiana 20
Orange 20
Phoenix 20
Zhengzhou 20
Totale 25.449
Nome #
Microemulsions of retinoids and pharmaceutical compositions containing them 1.971
Structural studies of lipid based nanosystems for drug delivery: X-Ray Diffraction (XRD) and Cryogenic Transmission Electron Microscopy (cryo-TEM) 410
Biodistribution of nanostructured lipid carriers: a tomographic study 335
Calcitermin-Loaded Smart Gels Activity against Candida albicans: A Preliminary In Vitro Study 322
Effect of new Curcumin-containing nanostructured lipid dispersions on human keratinocytes proliferative responses 297
Cannabinoid antagonist in nanostructured lipid carriers (NLCs): design, characterization and in vivo study 293
Aminated polysaccharide microspheres as DNA delivery systems 255
Nafion®-containing solid lipid nanoparticles as a tool for anticancer pt delivery: preliminary studies 252
Skin care: The innovative nanotechnology to improve the performance of delivery systems 247
Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity 244
Analysis of the drug release profiles from formulations based on micro and nano systems 235
Acrylic microspheres for oral controlled release of the biguanide buformin 235
Cationic lipospheres as delivery systems for nucleic acid molecules 234
Acyclovir delivery systems 234
Cationic lipid nanosystems as carriers for nucleic acids 234
Nuove strategie per la veicolazione di acidi nucleici: nanosistemi cationici a matrice lipidica 232
Nanostructured lipid carriers (NLC) for the delivery of natural molecules with antimicrobial activity: production, characterisation and in vitro studies 230
Amphiphilic association systems for amphotericin B delivery 227
Design and characterization of ethosomes for transdermal delivery of caffeic acid 227
Characterization Methods for Nanoparticle–Skin Interactions: An Overview 226
Clotrimazole Nanoparticle gel for mucosal administration. 220
Design of Nanosystems for the Delivery of Quorum Sensing Inhibitors: A Preliminary Study 220
Biodegradable microparticles for sustained delivery of tetracycline to the periodontal pocket: Formulatory and drug release studies 218
Lipid-based nanoparticles containing cationic derivatives of PTA (1,3,5-triaza-7-phosphaadamantane) as innovative vehicle for Pt complexes: production, characterization and in vitro studies 218
Cubosome dispersions as delivery systems for percutaneous administration of indomethacin 216
Data on scaling up and in vivo human study of progesterone lipid nanoparticles 215
Amphiphilic association systems for Amphotericin B delivery 214
Ursodeoxycholic acid for oral administration: a formulatory study of a suspension. 213
In situ forming gels as subcutaneous delivery systems of curcumin and piperine 209
Production of lipospheres as carriers for bioactive compounds 209
Monoolein Aqueous Dispersions as a delivery system for quercetin 208
L-dopa co-drugs in nanostructured lipid carriers: a comparative study 205
Nanostructured lipid systems modified with waste material of propolis for wound healing: design, in vitro and in vivo evaluation 204
Progesterone lipid nanoparticles: Scaling up and in vivo human study 204
Non-phospholipid vesicles as carriers for peptides and proteins: production, characterization and stability studies 202
Budesonide microparticles for the treatment of Crohn's disease 202
Ethosomes and organogels for cutaneous administration of crocin 202
Nanoparticulate lipid dispersions for bromocriptine delivery: characterization and in vivo study 201
Nanoformulations for dimethyl fumarate: Physicochemical characterization and in vitro/in vivo behavior 201
Encapsulation of cannabinoid drugs in nanostructured lipid carriers 199
Liposomes as carriers for DNA-PNA hybrids 198
Formulation study for the antitumor drug camptothecin: liposomes, micellar solutions and a microemulsion 198
Design and characterization of fenretinide containing organogels 197
Cationic lipid nanosystems as carriers for nucleic acids 197
Cationic liposomes as carriers for ocular administration of anti herpetic peptides 196
"Plurethosome" as vesicular system for cutaneous administration of mangiferin: formulative study and 3D skin tissue evaluation 196
Lipid nanocarriers containing a Levodopa prodrug with potential antiparkinsonian activity 196
Microparticles as delivery systems for local delivery to the oral cavity. 195
Cellulose acetate butyrate microcapsules containing dextran ion-exchange resins as self-propelled drug release system 195
Gallic acid loaded poloxamer gel as new adjuvant strategy for melanoma: A preliminary study 195
Nanosistemi lipidici per la veicolazione di acidi nucleici 194
Gelified reverse micellar dispersions as percutaneous formulations 193
Solid lipid nanoparticles for the delivery of 1,3,5-triaza-7-phosphaadamantane (PTA) platinum (ii) carboxylates 193
Influence of formulation and process parameters on pellet production by powder layering technique 192
A correlative imaging study of in vivo and ex vivo biodistribution of solid lipid nanoparticles 192
Nanostructured lipid dispersions for topical administration of crocin, a potent antioxidant from saffron (Crocus sativus L.) 191
Microparticles containing gallic and ellagic acids for the biological control of bacterial diseases of kiwifruit plants 191
Active substance controlled release device for sanitization of spaces susceptible of containing degenerative organic material 190
Challenges in the physical characterization of lipid nanoparticles 190
Effects of phospholipid based formulations on in vitro and in vivo percutaneous absorption of methyl nicotinate 186
Effect of nanostructured lipid vehicles on percutaneous absorption of curcumin 185
Polymeric microparticles for fenretinide administration 185
Intranasal immunization in mice with non-ionic surfactants vesicles containing HSV immunogens: a preliminary study as possible vaccine against genital herpes 185
Clotrimazole-loaded nanostructured lipid carrier hydrogels: thermal analysis and in vitro studies 184
Comparative analysis of tetracycline-containing dental gels: poloxamer- and monoglyceride-based formulations 183
Preparation of liposomes by reverse-phase evaporation using alternative organic solvents 182
Kinetics of bromocriptine release from microspheres: Comparative analysis between different in vitro models 181
Nanostructured lipid carriers as delivery systems for parkinson’s therapy 181
Eudragit® microparticles for the release of budesonide: A comparative study 181
Nanosystems for skin hydration: a comparative study 180
Curcumin containing monoolein aqueous dispersions: a preformulative study 179
Ethosomes and transethosomes for mangiferin transdermal delivery 178
Ethosomes and liposomes as topical vehicles for azelaic acid: A preformulation study 176
Lipid nanoparticles for administration of poorly water soluble neuroactive drugs 176
Long-chain cationic derivatives of PTA (1,3,5-triaza-7-phosphaadamantane) as new components of potential non-viral vectors 176
Liposome-associated retinoids: production, characterization and antiproliferative activity on neoplastic cells 175
Ethosomal Gel for Topical Administration of Dimethyl Fumarate in the Treatment of HSV-1 Infections 174
Cationic nanostructured lipid carrier (NLC) and monoolein aqueous dispersions (MAD) as potential carriers for nucleic acids 174
Cationic liposomes carrying anti herpetic peptides as potential ocular vaccine 174
Effect of cationic liposome composition on in vitro cytotoxicity and protective effect on carried DNA 174
In vitro cytotoxic activity of some glucosinolate-derived products generated by myrosinase hydrolysis 173
The potential of caffeic acid lipid nanoparticulate systems for skin application: in vitro assays to assess delivery and antioxidant effect 172
Microfluidic Fabricated Liposomes for Nutlin-3a Ocular Delivery as Potential Candidate for Proliferative Vitreoretinal Diseases Treatment 171
Lipid-based supramolecular systems for topical application: A preformulatory study 171
Dimethyl Fumarate-Loaded Transethosomes: A Formulative Study and Preliminary Ex Vivo and In Vivo Evaluation 169
Gelatin microspheres: Influence of preparation parameters and thermal treatment on chemico-physical and biopharmaceutical properties 169
Cationic phosphines for the obtaining of non-viral vectors 169
Pharmaceutical and biotechnological applications of multiple emulsions 168
Enhanced Anti-Melanoma Activity of Nutlin-3a Delivered via Ethosomes: Targeting p53-Mediated Apoptosis in HT144 Cells 167
Ethosomes for Curcumin and Piperine Cutaneous Delivery to Prevent Environmental-StressorInduced Skin Damage 167
Myrosinase-generated isothiocyanate from glucosinolates: Isolation, characterization and in vitro antiproliferative studies 167
Effect of charge and lipid concentration on in-vivo percutaneous absorption of methyl nicotinate from liposomal vesicles 166
Rheologic and NMR characterization of monoglyceride-based formulations 166
Production, physico-chemical characterization and biodistribution studies of lipid nanoparticles 166
Cubic Phases, Cubosomes and Ethosomes for Cutaneous Application 166
Properties and applications of liposomes in cosmetics 165
Production of lipospheres for bioactive compounds delivery 165
Comparative study on the release kinetics of methyl-nicotinate from topic formulations 165
GELATIN MICROSPHERES AS A NEW APPROACH FOR THE CONTROLLED DELIVERY OF SYNTHETIC OLIGONUCLEOTIDES AND PCR-GENERATED DNA FRAGMENTS 164
Influence of liposomal formulation parameters on the in vitro absorption of methyl nicotinate 163
Totale 21.927
Categoria #
all - tutte 163.513
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 7.752
Totale 171.265


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021171 0 0 0 0 0 0 0 0 0 0 0 171
2021/20222.024 92 248 148 124 56 101 116 135 71 185 185 563
2022/20232.079 239 64 70 232 344 351 66 205 269 16 144 79
2023/20241.178 134 116 53 31 85 230 70 77 23 42 61 256
2024/20255.286 148 122 391 177 708 521 185 392 933 477 764 468
2025/202615.910 1.313 659 1.257 1.805 1.895 870 1.552 880 3.186 1.628 607 258
Totale 37.839